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Abstract
Background: Systems biology and functional genomics require genome-wide datasets and resources. Complete
sets of cloned open reading frames (ORFs) have been made for about a dozen bacterial species and allow
researchers to express and study complete proteomes in a high-throughput fashion.
Results: We have constructed an open reading frame (ORFeome) collection of 3974 or 94% of the known
Escherichia coli K-12 ORFs in Gateway® entry vector pENTR/Zeo. The collection has been used for protein expression
and protein interaction studies. For example, we have compared interactions among YgjD, YjeE and YeaZ proteins
in E. coli, Streptococcus pneumoniae, and Staphylococcus aureus. We also compare this ORFeome with other
Gateway-compatible bacterial ORFeomes and show its utility for comparative functional genomics.
Conclusions: The E. coli ORFeome provides a useful resource for functional genomics and other areas of protein
research in a highly flexible format. Our comparison with other ORFeomes makes comparative analyses
straighforward and facilitates direct comparisons of many proteins across many genomes.
Background
High-throughput DNA sequencing has increased the
number of genome sequences to over 1,000 bacterial
species from which we can infer their proteomes and
often major parts of their metabolism and regulatory
pathways. A systems level understanding of cells, how-
ever, will require the functional characterization of these
proteins and how they work together. In recent years, a
growing number of efforts have used high throughput
assays to catalog gene expression, protein interactions,
localization and metabolic activities. For many of these
studies, the first step is to identify and then clone all the
open reading frames (the “ORFeome”)e n c o d e db yt h e
genome of the organism [1].
Here we describe the construction of a comprehensive
Escherichia coli ORF collection in a Gateway® [2] entry
vector. The library represents 3974 ORFs or 94% of all
protein-coding genes. The Gateway® system facilitates
t h et r a n s f e ro fO R F si n t oal a r g er a n g eo fe x p r e s s i o n
vectors that are suitable for downstream studies. Here
we demonstrate the utility of the E. coli ORFeome by
comparing it to 12 other available microbial ORFeomes
and by testing a set of protein-protein interactions
among 5 species.
The complete genome sequence of Escherichia coli K-
12 encodes 4333 protein-coding ORFs [3] (http://cmr.
jcvi.org/). Kitagawa et al. previously cloned all the E. coli
ORFs (the “ASKA library”)i n t oa ne x p r e s s i o nv e c t o r
creating N-terminal 6xHis and C-terminal GFP fusions
[4]. However, the ASKA library cannot be used to flex-
ibly transfer ORFs into other expression vectors [5,6].
Libraries of all open reading frames cloned into highly
flexible vectors will be needed to take full advantage of
the information found in any genome sequence. We
transferred the ASKA library [4] into an Gateway® entry
vector (pENTR/Zeo) by SfiI restriction enzyme cloning
(Figure 1). About 250 E. coli clones which were not pre-
sent in the ASKA library or which were not successfully
cloned from the ASKA library into the Gateway® entry
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Figure 1 E. coli entry clone libray construction and comparative ORFeomics. (A) Pipeline used to clone the E. coli ORFs into Gateway®
Entry vector (pENTR/Zeo). The total number of ORFs in common between E. coli K-12 MG1655 and E. coli K-12 W3110 is based on the more
accurate sequencing of these strains [14] and community re-annotation [3]. (B) Pairwise comparison of Clusters of orthologous genes (COGs) in
all species pairs. Colors indicate the similarity between species. For example, E. coli shares at least 60% of its COGs with most other species. The
species in the rows are ordered such that similar rows are near each other. (C) Presence of COGs in 14 species with available ORFeomes. For
example, 370 COGs are present in exactly 5 species (bars and left scale). The line represents the number of COGs that are present in a minimal
number of species, e.g. 2162 COGs are present in 4 or more species (right scale).
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(see Methods). The entry clone library was then vali-
dated by DNA sequencing. The resulting library repre-
sents 3974 ORFs (Additional file 1, Table S1). The
clone collection is freely available to academic users.
The E. coli entry clone library lacks start and stop
codons and is thus compatible with both N-terminal
and C-terminal expression clone constructions. The
clones from the entry vectors can be easily shuttled into
different Gateway-compatible expression vectors of
many types in a high-throughput fashion [5,6].
Results and Discussion
E. coli as a model for comparative genomics and biology
E. coli K-12 has led basic life science research for more
than half a century due to its easy manipulation and its
safety as a non-pathogenic organism. We wondered to
what extent it can also serve as model for pathogenic
bacteria and compared the E. coli ORFeome to all other
bacterial ORFeomes that are available as Gateway-com-
patible clones. Figure 1b shows how many E. coli genes
have orthologs in these species including Vibrio cho-
lerae, Yersinia pestis, Streptococcus pneumoniae and
others. For example, over 80% of E. coli COGs are con-
served in Pseudomonas aeruginosa (Figure 1b). COGs
(clusters of orthologous groups) represent conserved
protein families and provide a standard way to compare
gene sets [7]. We can safely assume that the general
molecular function of these E. coli proteins should be
similar or identical to these homologues in other bacter-
ial species. However, we cannot easily predict whether
small changes in sequence will change the function or
specificity of proteins. The availability of complete col-
lections of easily moveable cloned ORFs facilitates func-
tional studies in multiple species in parallel, even at the
level of whole proteomes. As of today, Gateway® clone
collections are available for at least 14 bacterial species
including 2 strains of Staphylococcus aureus (Figure 1B,
C, Additional file 1, Table S3). COGs should also facili-
tate comparative analysis, given that many of them are
present in species for which ORFeomes are available.
For example, 2162 COGs are present in at least four of
the species for which ORFeomes are available (Figure
1C).
The E. coli ORFeome for protein expression
We verified the functionality of the entry clones by two
different downstream applications. First, we tested
recombinant protein production in E. coli by randomly
selecting ten entry clones from the library that were
subsequently cloned into the Gateway® GST-fusion
expression vector pDEST-GST (see Methods). The
expression clones were transformed into the BL21(DE3)
protein expression strain of E. coli and after induction
of protein expression with IPTG, the cells were lysed in
sample buffer and analyzedb yW e s t e r nb l o t( F i g u r e
2A). Second, we tested protein interactions by the yeast
two hybrid assay. About 90 entry clones which are
known to be involved in bacterial motility (flagellum)
and chemotaxis were cloned into two different yeast
two-hybrid expression vector systems and 90×90 =
8,100 protein pair were tested for protein-protein inter-
actions, resulting in 177 protein-protein interactions [6].
The E. coli ORFeome for functional genomics and protein
interaction analysis
The availability of ORFeome collections will greatly
facilitate comparative functional genomic studies. An
example of this is to compare protein-protein interac-
tions among multiple species in order to determine
which interactions are conserved. Here we used the E.
coli ORF collection as well as previously generated S.
aureus and S. pneumoniae collections (http://pfgrc.jcvi.
org/) to systematically test, by yeast two-hybrid, whether
the recently described protein-protein interactions
between the essential E. coli gene products YgjD, YjeE
and YeaZ are conserved in these Gram-positive patho-
gens. These three proteins were selected as an interest-
ing case study because they are highly conserved,
essential, and of unknown function. The yjeE, yeaZ, and
ygjD genes are highly conserved throughout eubacterial
genomes while ygjD orthologs are also found throughout
the archaea and eukaryotes. We found all the interac-
tions that Handford et al. [8] reported but there were
significant differences between species (Figure B, C, D).
For example, YjeE and YeaZ from E. coli,b u tn o tf r o m
S. aureus or S. pneumoniae, interacted. The functions of
these genes remain poorly understood. In E. coli, yeaZ is
able to proteolyse ygjD while yjeE, an ATPase, competes
with ygjD for binding to yeaZ. The inability of yjeE to
interact with yeaZ in S. aureus and S. pneumoniae may
indicate differences in the regulation of the ygjD-yeaZ
complex in these species. Our study of these interac-
tions not only demonstrated differences between the
species tested but also showed another advantage of
such a comparative approach: the S. pneumoniae YjeE
as well as the the S. aureus YgjD protein autoactivated
the reporter genes when fused to the Gal4 DNA binding
domain. This property affects approximately 10% of bait
proteins in yeast two-hybrid assays [9]. However, while
the S. aureus YgjD bait is autoactivating, YgjD of E. coli
and S. pneumoniae are not (Figure 2B). Hence, com-
parative assays may offer one strategy for circumventing
limitations of the yeast two-hybrid method.
Additionally, by revealing which interactions are evo-
lutionarily conserved, such comparative studies will
greatly enhance our ability to interpret the conserved
biological functions of the interacting proteins, and also
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Figure 2 Functional ORFeomics. (A) Recombinant protein expression in E. coli. Western blot of 10 GST-tagged E. coli recombinant proteins.
After induction of protein expression with IPTG, the cells were lysed and the crude lysates were analyzed by Western blot and antibody
detection with anti-GST antibodies. The expected band sizes are marked by arrow heads, the lower molecular weight bands of DnaE are the
results of protein degradation (B, C) E. coli, S. aureus and S. pneumoniae YgjD, YjeE and YeaZ proteins were tested by the yeast two-hybrid
method for interactions. “+” indicate a positive protein interaction and “-” indicate no protein interaction; the pGADT7g-vector is a negative
control (for autoactivation); uncertain interactions due to autoactivation are indicated by “A”. (C) Intraspecies and interspecies protein interactions
of YgjD and YeaZ of E. coli, S. aureus, S. pneumoniae, H. pylori, and R. prowazekii (as in B). (D) Interpretation of Figures (B) and (C). Crystal
structures are available for YeaZ (PDB: 1OKJ), YjeE (1HTW-A), and YgjD (2IVO), but only YeaZ has been crystallized from E. coli. Comparative
analyses show conserved residues and thus potential interaction sites (red: most, blue: least conserved). The strongest interactions (thick lines)
also tend to be the most conserved ones.
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protein interaction datasets [10]. For example, crystal
structures are available for all three interacting proteins,
but only one from E. coli, namely YeaZ (Figure 2D). In
order to obtain more information for model building
and functional interactions, we expanded our test set
beyond E. coli and tested the interactions among YgjD,
YeaZ, and YjeE in five different species, including H.
pylori and R. prowazekii. In addition to the expected
intraspecies interactions, interspecies interactions were
observed (Figure 2C). The S. aureus YeaZ protein asso-
ciated with the products of the E. coli and S. pneumo-
niae orthologs of ygjD while the S. pneumoniae YeaZ
protein was able to interact with H. pylori YgjD. This
last interaction was particularly unexpected as yeaZ is
not conserved in H. pylori, and suggests the possibility
that the functions of yeaZ may be performed by another
protein in this species.
Given the availability of ORFeomes for more than a
dozen species, such comparative analyses can now be
carried out quite easily. More importantly, additional
biochemical or genetic studies can be done in E. coli for
which extensive resources, including deletion strains
[11,12] and comprehensive databases (http://www.
PrFEcT.org > Resources), are available. For instance, our
E. coli clones could be used to complement mutants in
other species, which would demonstrate their functional
equivalence.
Conclusions
In conjunction with other clone sets and the vast
amount of genomics and proteomics data from E. coli,
the Gateway-ORFeome will be another highly useful
resource for the E. coli functional genomics community.
Methods
Cloning the E. coli ORFs from ASKA library to Gateway®
entry vector
In order to transfer the ASKA library [4] into the Gate-
way® entry vector pENTR/Zeo, the ASKA library plas-
mids (in pCA24N) were first digested with SfiI to
release the ORFs. The purified ORFs were then ligated
into the SfiI-digested pENTR/Zeo vector (Figure 3C).
The ligation reaction was then transformed into E. coli
DH5-alpha competent cell and plated on LB-Zeocin
agar plates. We picked 4 isolated colonies for each reac-
tion and verified them for the chloromphenicol antibio-
tic sensitivity and the size of insert by colony PCR. The
correct clones were re-arrayed and the plasmids isolated.
The insert ORFs were verified by DNA sequencing (see
sequence validation).
About 250 E. coli clones which were not present in
the ASKA library or not successfully ligated from the
ASKA library into the Gateway® entry vector were
cloned by Gateway® recombinational cloning [2]. The
PCR products were inserted into the Gateway® entry
vector pDONR™/Zeo (Invitrogen) by BP-cloning. The
products resulting from site-specific recombination were
transformed into E. coli and plated onto solid LB med-
ium containing Zeocin. Two isolated colonies were
selected for each reaction and the clones were verified
by colony-PCR with pDONR™/Zeo-specific primers. The
clones that had an insert of the expected size were
picked for plasmid isolation and the plasmid was used
as a template for DNA sequencing to verify the insert
sequence.
Colony PCR of bacterial clones
We selected four isolated colonies for each pENTR/Zeo
clone to verify the cloned ORF size. Colonies were
picked with a sterile pipette tip and transferred to the
wells of a 96-well plate containing 150 μll o w - s a l tL B
liquid medium containing 50 μg/ml Zeocin™ and incu-
bated overnight at 37°C to generate glycerol long-term
frozen stocks. 1 μl of bacterial culture was used for col-
ony PCR in 96-well plates containing 50-μl samples
with Biomix™ ( B i o l i n e ,C a t .N o .B I O - 2 5 0 1 2 ) ,p D O N R ™/
Zeo-specific forward primer (5′-GTAAAACGACGGC-
CAG-3′) and reverse primer (5′-CAGGAAACAGCTAT-
GAC-3′) (0.3 μM each). The 30 PCR cycles (94°C for 30
s, 55°C for 30 s, and 72°C for 1 min/kb) were preceded
by heating to 94°C for 5 min and followed by a 7-min
incubation at 72°C. The sizes of the PCR products were
determined by agarose gel electrophoresis and ethidium
bromide staining.
Primer design
The DNA sequence of E. coli strain K-12 was obtained
f r o mt h eJ C V I / C M RG e n o m eD a t abase (http://cmr.jcvi.
org/cgi-bin/CMR/CmrHomePage.cgi) and primers were
designed for clones which were cloned by Gateway®
recombination (Figure 3), using the primer design tool
(http://tools.bio.anl.gov/bioJAVA/jsp/ExpressPrimer-
Tool/). The primers are designed without endogenous
start and stop codons. In addition to a 20- to 30-nucleo-
tide-long ORF-specific sequence the attB1 segment (5′-
aaaaagcaggctta-3′) was added to each forward primer,
followed by ORF-specific bases without a start codon.
The attB2 segment (5′-agaaagctgggtg-3′) was added at
the 5′ end of each reverse primer, which was comple-
mentary to the end of the ORF, without the last nucleo-
tide of the stop codon. The primers were obtained from
Invitrogen in a 96-well format.
PCR amplification of the ORFs
For the clones constructed by Gateway® recombinational
cloning, PCR was performed in 96-well plates containing
50-μl reaction volumes consisting of 1 U KOD DNA
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R.( B) Construction of pENTR/Zeo by BP recombination with pDONR™/Zeo. The
resulting vector has attL1, attL2 sites and two SfiI sites bordering the Cm
R fragment. (C) The E. coli ORFs of pCA24N were then transferred by SfiI
digestion, gel-fractionated and ligated into SfiI-digested pENTR/Zeo vector. The positive clones are selected for Zeocin resistance and
Chloramphenicol sensitivity, and are validated by PCR and DNA sequencing (see methods).
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Page 6 of 8polymerase (Novagen), dNTP mix (0.4 mM each), pri-
mary forward and reverse primers (0.3 μMe a c h ) ,a n d
E. coli K-12 strain W3110 genomic DNA (200 ng).
T h ec o m p l e t es e q u e n c e so fattB1 (5′-GGGGA-
CAAGTTTGTACAAAAAAGCAGGCT-3′)a n dattB2
(5′-GGGGACCACTTTGTACAAGAAAGCTGGGT-3′)
were added in the secondary round PCR, where the first
round PCR product was used as a template, to generate
the full-length attB1 and attB2 sites flanking the ORFs.
The PCR cycles were used as recommended by the
KOD DNA polymerase manufacturer (Novagen, Cat.
No.710853). These PCR products were used for BP
reaction.
attB × attP recombination reactions (BP reactions)
The PCR-amplified ORFs with attB1 and attB2 sites
were recombined into the vector pDONR™/Zeo (Invitro-
gen) by using the BP Clonase™ II Enzyme Mix (Invitro-
gen). In 96-well plates, samples containing 1 μlp u r i f i e d
PCR product, 1 μlB PC l o n a s e ™ II Enzyme Mix, 75 ng
pDONR™/Zeo plasmid and TE buffer, pH 8.0, up to 5 μl
were incubated overnight at 25°C. After adding 1 μg
proteinase K (Invitrogen) and incubating at 37°C for 30
minutes, the BP reactions were directly used for bacter-
ial transformation.
attL × attR recombination reactions (LR reactions)
Entry vectors were set up in LR reactions to recombine
the gene of interest into several destination vectors
(expression vectors). The destination vectors used were
pDEST22, pDEST32 (Invitrogen), pGADT7g, pGBGT7g
and pDEST-GST vectors. Samples containing 5 μlp r e -
pared entry clone, 1 μlL RC l o n a s e ™ II Enzyme Mix
(Invitrogen), destination vector (150 ng), and TE buffer,
pH 8.0 to 10 μl were incubated at 25°C for two hours.
After adding 1 μg proteinase K (Invitrogen) and incubat-
ing at 37°C for 30 min, the LR reactions were directly
used for plasmid transformation into E. coli.
Validation of entry clones by DNA sequencing
To sequence verify the inserted ORFs we re-arrayed
each clone which showed the right size as a PCR pro-
duct. All these clones were grown on 1.2 ml LB-Zeocin
liquid medium in 96 deep well plates (2 ml Qiagen). An
aliquot of this culture (50 ul) was used to make a gly-
cerol stock for longer storage. The plasmid DNA was
isolated by using 96 well plasmid preparation plates
(Millipore), and the plasmid preparations were
sequenced with a pDONR™/Zeo-specific forward primer
and reverse primers to verify the insert from both N-
terminal and C-terminal ends of the ORFs. All the
sequencing reads were analyzed using NCBI stand alone
BLAST against the E. coli K-12 genome database to con-
firm the identity of each ORF. The clone verification
was classified into three categories based on the sequen-
cing coverage of the insert, class A:i n s e r ti sv e r i f i e d
from both N and C-terminal ends; class B: insert is veri-
fied either from N or C-terminal ends (Additional file 1,
Table S1); class C: unverified (or sequence failed).
Validation of entry clones by recombinant protein
production
In order to verify the functionality of the ORFeome, a
random sample was used to show expression of proteins
from the cloned ORFs. Ten different E. coli entry clones
were shuttled into the pDEST-Exp vector designed to
make a fusion protein with a GST-Tag. The resulting
expression vectors were transformed into the BL21
(DE3) protein expression strain of E. coli. After induc-
tion of protein expression with IPTG, the cells were
lysed and the crude lysates were analyzed by western
blot and antibody detection anti-GST antibodies. Protein
was expressed from all 10 of the GST-tagged proteins
we tested (Figure 2A).
Yeast two-hybrid analysis
The yeast two-hybrid assay is conducted as described by
Rajagopala et al. (Rajagopala et al. 2007b).
Homology of bacterial ORFeomes
The cluster of orthologous group (COGs) for all the 14
bacterial species for which cloned ORFeomes are avail-
able (Additional file 1, Table S3), were extracted from
the STRING database [13]. This table was used to
obtain orthologous protein information between differ-
ent bacterial species based on COGs relationship. The
COGs from Escherichia coli K-12 (strain W3110) were
used as reference to obtain homologous proteins in 14
different bacterial species (including two strains of Sta-
phylococcus aureus, Col and Mu50; only Col was used
for the COG analysis though). Similarly, by taking each
of these 14 species as reference, the homologues for the
rest of the species were extracted. Unique proteins from
each species in the COGs were taken and the fraction of
these out of all the predicted protein coding genes of
the respective genome was used to calculate the percen-
tage of homologous proteins. The matrix with all these
values with reference as well as other species was made
and used to generate a heat map in order to represent
the percentage of homologous proteins in different spe-
cies (Figure 1B).
Additional material
Additional file 1: Supplementary Tables S1-S5. S1: All E. coli ORFs; S2:
ORFs not targeted; S3: list of available ORFeomes; S4: Yeast two-hybrid
interactions; S5: homologous ORFs in other species organized by COGs
(clusters of orthologous groups/genes).
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